Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

NCT00061360 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

NIH

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: ATG+Rapamune+cyclosporine
DRUG: ATG+cyclosporine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)